Kinarus Therapeutics Holding AG
SIX:CURN
Kinarus Therapeutics Holding AG
SIX:CURN
Price:
19.75
CHF
-2.71%
Market Closed
Market Cap:
CHf104.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kinarus Therapeutics Holding AG
SIX:CURN
|
CH |
|
T
|
Toronto-Dominion Bank
XMUN:TDB
|
CA |
|
S
|
Silvercorp Metals Inc
XBER:S9Y
|
CA |
|
B
|
Berkshire Hathaway Inc
XBER:BRH
|
US |
|
C
|
CITIC Securities Co Ltd
HKEX:6030
|
CN |
|
Basic Fit NV
F:B4F
|
NL |
|
Ryohin Keikaku Co Ltd
TSE:7453
|
JP |
|
Samsung Biologics Co Ltd
KRX:207940
|
KR |
|
C
|
Clorox Co
F:CXX
|
US |
|
P
|
PTC Therapeutics Inc
XBER:BH3
|
US |
|
U
|
Unilever PLC
DUS:UNVB
|
UK |
|
E
|
Eni SpA
XHAM:ENI
|
IT |
|
H
|
H & R Block Inc
DUS:HRB
|
US |
|
B
|
Bloom Energy Corp
SWB:1ZB
|
US |
|
U
|
UniCredit SpA
XETRA:CRIN
|
IT |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of CURN.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CURN
Multiples-Based Value
Base Case
Not Available
